Align Technology: A Productive Sell-Side Tech Talk

Research evidence excerpt

Align Technology: A Productive Sell-Side Tech Talk

Idea

May 28, 2026 01:39 AM GMT

Morgan Stanley & Co. LLCMAlign Technology | North America Erin Wright

Equity Analyst

A Productive Sell-Side Tech Talk Erin.Wright1@morganstanley.comLinda Bolduc +1 212 761-6137

Linda.Bolduc@morganstanley.com +1 617 856-8009

We met with ALGN today, where it reinforced its differentiated Michelle Foley

digital platform that clearly sets it apart. While the event lacked Research Associate

Michelle.Foley@morganstanley.com +1 212 761-4056

detailed financials (as expected), we are encouraged by new Natasha Arya

stepped up initiatives to drive conversion. We walk away ResearchNatasha.Arya@morganstanley.comAssociate +1 212 761-6294

incrementally constructive. Craig Hettenbach

Craig.Hettenbach@morganstanley.com +1 212 761-6435

Key Takeaways John Y Park

Research Associate

Digital workflows, scale, and innovation reinforce ALGN’s differentiated clear John.Park@morganstanley.com +1 212 761-4029

aligner ecosystem and broader positioning as an oral health platform. Jialin Jin

New initiatives: ART lab partnerships/recent pilot, financing tools, Zero AA & DSP Jay.Jin@morganstanley.com +1 212 761-3913

are designed to lower barriers for GPs and improve treatment conversion.

Align Technology Inc (ALGN.O, ALGN US)

Direct fabrication investments and proprietary material innovation support LT Specialty Pharmaceuticals | United States of America

manufacturing differentiation, though acknowledging scaling will take time. Stock Rating Equal-weight

Industry View In-Line

Virtual care and compliance tools are improving engagement and may reduce Price target $188.00

Shr price, close (May 26, 2026) $163.55

office visits by ~30%, supporting provider efficiency and patient convenience.

Mkt cap, curr (mm) $11,491